Immunogenic cell death in cancer and infectious disease

  title={Immunogenic cell death in cancer and infectious disease},
  author={L. Galluzzi and A. Buqu{\'e} and O. Kepp and L. Zitvogel and G. Kroemer},
  journal={Nature Reviews Immunology},
  • L. Galluzzi, A. Buqué, +2 authors G. Kroemer
  • Published 2017
  • Biology, Medicine
  • Nature Reviews Immunology
  • Immunogenicity depends on two key factors: antigenicity and adjuvanticity. The presence of exogenous or mutated antigens explains why infected cells and malignant cells can initiate an adaptive immune response provided that the cells also emit adjuvant signals as a consequence of cellular stress and death. Several infectious pathogens have devised strategies to control cell death and limit the emission of danger signals from dying cells, thereby avoiding immune recognition. Similarly, cancer… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Paper Mentions

    A multicentre single arm phase II trial assessing the efficacy of immunotherapy, chemotherapy plus stereotactic radiotherapy to metastases followed by definitive surgery or radiotherapy… Expand
    ConditionsNon-small Cell Lung Cancer, Oligometastasis, Stage IV
    InterventionDrug, Procedure, Radiation
    Control of Metastasis by NK Cells.
    • 186
    The P2X7 Receptor in Infection and Inflammation
    • 261
    Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
    • 952
    • PDF
    Biological Functions of Autophagy Genes: A Disease Perspective
    • 265
    DNA Damage and Repair Biomarkers of Immunotherapy Response.
    • 169
    • PDF


    Publications referenced by this paper.
    Immunogenic cell death in cancer therapy.
    • 1,329
    Hallmarks of Cancer: The Next Generation
    • 27,096
    • PDF
    Neoantigens in cancer immunotherapy
    • 2,080
    • PDF